<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00336687</url>
  </required_header>
  <id_info>
    <org_study_id>CHU63-0013</org_study_id>
    <nct_id>NCT00336687</nct_id>
  </id_info>
  <brief_title>Study of Incidence, of Mechanisms and Prognosis of the Thrombopenia From Patients of Reanimation.</brief_title>
  <official_title>Study of Incidence, of Mechanisms and Prognosis of the Thrombopenia From Patients of Reanimation.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Clermont-Ferrand</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Moulins Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centre Hospitalier Universitaire de Saint Etienne</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>LA ROCHE SUR YON HOSPITAL</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Clermont-Ferrand</source>
  <brief_summary>
    <textblock>
      About 40 % of the patients in reanimation are thrombopenics and the causes are not well known
      (reduction in platelet's production, increase in their destruction...). This protocol studies
      the epidemiology of thrombopenia for these patients and the impacts of cost and mortality in
      order to bring patients best medical cares.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      About 40 % of the patients in reanimation are thrombopenics and the causes are not well known
      (reduction in platelet's production, increase in their destruction...). This protocol studies
      the epidemiology of thrombopenia for these patients and the impacts of cost and mortality in
      order to bring patients best medical cares.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2005</start_date>
  <completion_date type="Actual">November 2006</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Epidemiology of Thrombopenia and its consequences.</measure>
    <time_frame>in reanimation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The impact of cost and mortality of Thrombopenia in reanimation.</measure>
    <time_frame>in reanimation</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">322</enrollment>
  <condition>Thrombopenia</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients of Reanimation
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Thrombopenia in reanimation

        Exclusion Criteria:

          -  Pregnancy

          -  Contraindication of myelogram
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fabrice Thiolliere, Dr</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital, Clermont-Ferrand</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clermont-Ferrand University Hospital</name>
      <address>
        <city>Clermont-Ferrand</city>
        <state>Auvergne</state>
        <zip>63000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 13, 2006</study_first_submitted>
  <study_first_submitted_qc>June 13, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 14, 2006</study_first_posted>
  <last_update_submitted>March 26, 2010</last_update_submitted>
  <last_update_submitted_qc>March 26, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 29, 2010</last_update_posted>
  <responsible_party>
    <name_title>Fabrice Thiolli√®re</name_title>
    <organization>CHU Clermont-Ferrand</organization>
  </responsible_party>
  <keyword>Thrombopenia</keyword>
  <keyword>Reanimation</keyword>
  <keyword>Thrombopenia in reanimation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thrombocytopenia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

